Rujescu D

Department of Psychiatry, Medical University of Vienna (CINP), Vienna, Austria.

5 papers

ArticleKetamine

Global perspectives on central nervous system drug innovation: achievements, barriers, and priorities for the next decade.

Uchida H, Gobbi G, Zohar J +7

Europe PMC2026
ArticleKetamine

Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.

Diendorfer CM, Bum C, Weidenauer A +7

Europe PMC2026
ArticleKetamine

Human <i>in vivo</i> assessment of ketamine binding of the serotonin transporter-follow up at a higher dose.

Schlosser G, Murgaš M, Godbersen GM +10

Europe PMC2025
ArticleKetamine

The role of esketamine in persistent long COVID with predominant psychiatric manifestations.

Bozic I, Ivkic D, Reinfried L +11

Europe PMC2025
ArticleKetamine

Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy.

Baldinger-Melich P, Spies M, Bozic I +3

Europe PMC2025